nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An influenza vaccine pill—can we swallow it?
|
Fast, Patricia E |
|
2015 |
15 |
9 |
p. 992-993 2 p. |
artikel |
2 |
Antimicrobial stewardship and public knowledge of antibiotics
|
Hwang, Thomas J |
|
2015 |
15 |
9 |
p. 1000-1001 2 p. |
artikel |
3 |
Artemisinin resistance in Myanmar
|
Plowe, Christopher V |
|
2015 |
15 |
9 |
p. 1001-1002 2 p. |
artikel |
4 |
Artemisinin resistance in Myanmar – Authors' reply
|
Imwong, Mallika |
|
2015 |
15 |
9 |
p. 1002-1003 2 p. |
artikel |
5 |
CAP death: what goes wrong when everything is right?
|
Wunderink, Richard G |
|
2015 |
15 |
9 |
p. 995-996 2 p. |
artikel |
6 |
Ceftaroline fosamil for community-acquired pneumonia
|
Pawluk, Shane Ashley |
|
2015 |
15 |
9 |
p. 999- 1 p. |
artikel |
7 |
Ceftaroline fosamil for community-acquired pneumonia – Authors' reply
|
Zhong, Nan Shan |
|
2015 |
15 |
9 |
p. 999-1000 2 p. |
artikel |
8 |
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report
|
Schibler, Manuel |
|
2015 |
15 |
9 |
p. 1034-1040 7 p. |
artikel |
9 |
Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study
|
Lado, Marta |
|
2015 |
15 |
9 |
p. 1024-1033 10 p. |
artikel |
10 |
Clinical value of whole-genome sequencing of Mycobacterium tuberculosis
|
Takiff, Howard E |
|
2015 |
15 |
9 |
p. 1077-1090 14 p. |
artikel |
11 |
Concerns raised over water quality at the Rio Olympics
|
The Lancet Infectious Diseases, |
|
2015 |
15 |
9 |
p. 987- 1 p. |
artikel |
12 |
Corrections
|
|
|
2015 |
15 |
9 |
p. 998- 1 p. |
artikel |
13 |
Corrections
|
|
|
2015 |
15 |
9 |
p. 998- 1 p. |
artikel |
14 |
Corrections
|
|
|
2015 |
15 |
9 |
p. 998- 1 p. |
artikel |
15 |
Corrections
|
|
|
2015 |
15 |
9 |
p. 998- 1 p. |
artikel |
16 |
Corynebacterium ulcerans cutaneous diphtheria
|
Moore, Luke S P |
|
2015 |
15 |
9 |
p. 1100-1107 8 p. |
artikel |
17 |
Differences in BCG vaccination and tuberculin skin-test positivity
|
Sidibe, Anissa |
|
2015 |
15 |
9 |
p. 1003- 1 p. |
artikel |
18 |
Differences in BCG vaccination and tuberculin skin-test positivity – Authors' reply
|
Gao, Lei |
|
2015 |
15 |
9 |
p. 1003-1005 3 p. |
artikel |
19 |
Dried blood spot for Ebola testing in developing countries
|
Sarkar, Subhabrata |
|
2015 |
15 |
9 |
p. 1005- 1 p. |
artikel |
20 |
Drug trials in the hot zone
|
Sansom, Clare |
|
2015 |
15 |
9 |
p. 1009-1010 2 p. |
artikel |
21 |
Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission
|
Klein, Nigel |
|
2015 |
15 |
9 |
p. 1108-1114 7 p. |
artikel |
22 |
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities
|
Plucinski, Mateusz M |
|
2015 |
15 |
9 |
p. 1017-1023 7 p. |
artikel |
23 |
Emergent chikungunya virus and arthritis in the Americas
|
Rolph, Michael S |
|
2015 |
15 |
9 |
p. 1007-1008 2 p. |
artikel |
24 |
Highlights from IAS 2015
|
Hayward, Peter |
|
2015 |
15 |
9 |
p. 1012- 1 p. |
artikel |
25 |
High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
|
Liebowitz, David |
|
2015 |
15 |
9 |
p. 1041-1048 8 p. |
artikel |
26 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
2015 |
15 |
9 |
p. 1014- 1 p. |
artikel |
27 |
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study
|
Kohli, Anita |
|
2015 |
15 |
9 |
p. 1049-1054 6 p. |
artikel |
28 |
Ledipasvir–sofosbuvir for hepatitis C genotype 4 infection
|
Smith, Michael A |
|
2015 |
15 |
9 |
p. 993-995 3 p. |
artikel |
29 |
Malaria kills more than Ebola virus disease
|
Pagnoni, Franco |
|
2015 |
15 |
9 |
p. 988-989 2 p. |
artikel |
30 |
Meningitis outbreak in Niger is an urgent warning
|
Burki, Talha |
|
2015 |
15 |
9 |
p. 1011- 1 p. |
artikel |
31 |
Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis
|
Nanoo, Ananta |
|
2015 |
15 |
9 |
p. 1066-1076 11 p. |
artikel |
32 |
Para-aminosalicylic acid: the return of an old friend
|
Donald, Peter R |
|
2015 |
15 |
9 |
p. 1091-1099 9 p. |
artikel |
33 |
Population-level tuberculosis incidence in the ART era
|
Hermans, Sabine |
|
2015 |
15 |
9 |
p. 997-998 2 p. |
artikel |
34 |
Research brief
|
Bradbury, Jane |
|
2015 |
15 |
9 |
p. 1015- 1 p. |
artikel |
35 |
Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study
|
Shindo, Yuichiro |
|
2015 |
15 |
9 |
p. 1055-1065 11 p. |
artikel |
36 |
Rocky Mountain spotted fever in Native Americans
|
Nelson, Roxanne |
|
2015 |
15 |
9 |
p. 1013-1014 2 p. |
artikel |
37 |
The velocity of Ebola spread in parts of west Africa
|
Zinszer, Kate |
|
2015 |
15 |
9 |
p. 1005-1007 3 p. |
artikel |
38 |
The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry?
|
Zachariah, Rony |
|
2015 |
15 |
9 |
p. 989-990 2 p. |
artikel |
39 |
Towards deep insight into Ebola virus disease
|
Baize, Sylvain |
|
2015 |
15 |
9 |
p. 991-992 2 p. |
artikel |
40 |
Tuberculosis
|
McNerney, Ruth |
|
2015 |
15 |
9 |
p. 1016- 1 p. |
artikel |